Form CORRESP - Correspondence:
SEC Accession No. 0001628280-24-034108
Filing Date
2024-08-01
Accepted
2024-08-01 16:01:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10949
2 GRAPHIC avalo-logoxblk1a.jpg GRAPHIC 99614
  Complete submission text file 0001628280-24-034108.txt   149186
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)